CG Oncology Inc.

Contributing Author

Recent Articles by CG Oncology Inc.

3 hours	SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award CGON GlobeNewswire
Dec-05	New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer CGON GlobeNewswire
Nov-26	CG Oncology Announces New Board Member and Board Transition CGON GlobeNewswire
Nov-25	CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting CGON GlobeNewswire
Nov-14	CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates CGON GlobeNewswire
Sep-05	CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months CGON GlobeNewswire
Sep-03	CG Oncology Completes Enrollment in PIVOT-006 CGON GlobeNewswire
Aug-29	CG Oncology's Executive Leadership to Participate in Upcoming Investor Conferences CGON GlobeNewswire
Aug-08	CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates CGON GlobeNewswire
Jul-29	Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals CGON GlobeNewswire
Jun-05	CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference CGON GlobeNewswire
May-15	CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference CGON GlobeNewswire
May-13	CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates CGON GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.